Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-025633

Chief Accounting Officer sold 96 shares at $10.08 ($967)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-21 Sale : show line 1 in the form −96 $10.08 $967 2,832 D
Open-market sales · 96 sh · avg $10.08 · $967
Loading xslF345X05/ownership.xml…